Skip to search.
 TSX Up 0.60% TSX Ventures Up 1.02%

Abbott Laboratories (ABT)

-NYSE
50.69 Down 0.08(0.16%) 4:03PM EDT
|After Hours : 50.69 0.00 (0.00%) 4:27PM EDT
Add to Portfolio
Prev Close:50.77
Open:51.07
Bid:50.30 x 100
Ask:50.91 x 200
1y Target Est:53.34
Beta:1.24
Earnings Date:Oct 20 - Oct 26 (Est.)
Day's Range:50.60 - 51.13
52wk Range:39.28 - 51.74
Volume:5,552,769
Avg Vol (3m):4,942,930
Market Cap:75.47B
P/E (ttm):17.03
EPS (ttm):2.98
Div & Yield:0.96 (1.90%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABTDown 0.16%75.47B
NSRGYUp 0.02%239.53B
RHHBYUp 0.17%245.91B
TEVADown 0.07%58.53B

Key Statistics

Forward P/E (1 yr):20.95
P/S (ttm):3.69
Ex-Dividend Date:13-Jul-15

Analysts

Annual EPS Est (Dec-15) :2.16
Quarterly EPS Est (Sep-15) :0.54
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.46

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; int... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback